Allogeneic natural killer cells with Pin engineered anti-EGFR antibody
Developing novel mRNA-based cancer therapies targeting solid tumors with high unmet need.
Precision medicine approach for autoimmune disorders using proprietary antibody-drug conjugate technology.
Targeting neurological disorders through blood-brain barrier penetrant small molecules.
Upgrade to access detailed therapeutic area information for this company and unlock all premium features.
